Vaccines are playing an increasingly important role in disease prevention. It is common knowledge that biological agents are unstable in the storage process, which will reduce the safety and effectiveness of biomedical products. With vaccine identity testing, vaccine purity testing, and vaccine microbial testing, Creative Biolabs also perform vaccine stability testing in accordance with the WHO specification on vaccine stability, which is adopted by the Expert Committee on Biological Standardization (ECBS), we are committed to proving that vaccine product with obvious merits such as acceptable quality, efficacy, and safety under certain storage conditions.
Creative Biolabs not only provides a general vaccine stability assessment but also offers one-stop stability assessment services for vaccine production and subsequent use.
Our vaccine cold chain technology can effectively reduce the sensitivity of vaccines to environmental temperature.
We provide customized design services for vaccine research according to the needs of customers.
In the data analysis, we offer scientific statistical methods, that is, testing a certain index at different points in a period of time, evaluating the final results statistically, conducting the average calculation and data analysis.
Proteins and other macromolecules are sensitive to heat, light, radiation, environmental changes, or may interact with container materials or other components of a vaccine mixture. Therefore, identifying their relationships and optimizing stability from production to administration to patient are extremely significant and meaningful for vaccine development. Even under the most ideal conditions, its effectiveness may gradually weaken with the passage of time since production.
We offer a variety of analytical techniques for stability testing:
Creative Biolabs has high-quality vaccine production management norms, production workshops, and strict biosafety equipment, as well as relevant research support services. We are committed to providing you with satisfactory vaccine stability detection technology.
Please feel free to contact us and get more detailed information.
For any technical issues or products/services related questions, please leave your contacts as below, and our team will contact you at earliest convenience to let you know how we can be involved in your projects.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy with the complete TCR without HLA dependence.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE